Commercialization in Bioengineering: Starting with the Need and Not the Technology

Traditionally, innovation has started with technology looking for a need. However, the complexities and variety of stakeholders involved in commercialization in biomedical technology call for a different approach - to lead with the need.

Innovation in the biomedical field is coming from a new perspective. At the Stanford Byers Center for Biodesign, today’s bioengineering vanguards are trained to select, research and categorize needs before embarking on the process of inventing. This approach is increasing productivity and helping to better meet the unique needs of the health technology community. Gordon Saul, executive director, explores the process of need-led biodesign and discusses real world applications of this methodology. 

Sign in to view

Please sign in or register for an account to be able to access this piece of content.

Sign In